Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease

Trends in Molecular Medicine

Volumn 9, Issue 3, 2003, Pages 94-101

  Poirier, Judes ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; MEVINOLIN; PROBUCOL;

ALZHEIMER DISEASE; ANIMAL MODEL; BRAIN METABOLISM; CARDIOVASCULAR RISK; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; DEMENTIA; GENE LOCUS; GENETIC EPIDEMIOLOGY; GENETIC RISK; HUMAN; HYPERTENSION; LIPID BRAIN LEVEL; LIPID METABOLISM; PATHOGENESIS; PATHOPHYSIOLOGY; PROPHYLAXIS; PROTEIN DEGRADATION; REVIEW; RISK FACTOR; STROKE;

ANIMALIA;

EID: 0037359765     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00007-8     Document Type: Review

References (35)

1. Tanzi, R.E. and Bertram, L. (2001) New frontiers in Alzheimer's disease genetics. Neuron 32, 181-184
2. Poirier, J. et al. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699
3. Strittmatter, W.J. et al. (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90, 1977-1981
4. Kalaria, R.N. and Ballard, C. (1999) Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis. Assoc. Disord. 13 (Suppl. 3), S115-S123
5. 18F]fluoro-2-deoxy-D-glucose/ positron-emission tomography (FDG/PET). Proc. Natl. Acad. Sci. U. S. A. 98, 10966-10971
6. Reiman, E.M. et al. (2001) Declining brain activity in cognitively normal apolipoprotein E ε4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 98, 3334-3339
7. Skoog, I. (2000) Vascular aspects in Alzheimer's disease. J. Neural Transm. Suppl. 59, 37-43
8. Luchsinger, J.A. et al. (2002) Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 59, 1258-1263
9. Peila, R. et al. (2001) Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study. Stroke 32, 2882-2889
10. Mulnard, R.A. et al. (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's disease cooperative study. JAMA 283, 1007-1015
11. Distl, R. et al. (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol. (Berl.) 101, 547-554
12. Mulder, M. et al. (1998) Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis. Assoc. Disord. 12, 198-203
13. Poirier, J. (2002) Cholesterol transport and synthesis are compromised in the brain in sporadic Alzheimer's disease: From risk factors to therapeutic targets. In Alzheimer's Disease and Related Disorders Annual (Gauthier, S. and Cummings, J.L., eds) pp. 1-23, Dunitz
14. Svennerholm, L. and Gottfries, C.G. (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62, 1039-1047
15. Mason, R.P. et al. (1992) Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol. Neurobiol. Aging 13, 413-419
16. Giubilei, F. et al. (1990) Serum lipoprotein pattern variations in dementia and ischemic stroke. Acta Neurol. Scand. 81, 84-86
17. Jarvik, G.P. et al. (1995) Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 45, 1092-1096
18. Roher, A.E. et al. (1999) Amyloid and lipids in the pathology of Alzheimer disease. Amyloid 6, 136-145
19. Kehoe, P. et al. (1999) A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 8, 237-245
20. Yasojima, K. et al. (2001) 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brain. Neuroreport 12, 2935-2938
21. Poirier, J. et al. (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55, 81-90
22. Nathan, B.P. et al. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852
23. Poirier, J. et al. (1995) Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann. Med. 27, 663-670
24. Beffert, U. et al. (1996) Apolipoprotein E uptake is increased by β-amyloid peptides and reduced by blockade of the LDL receptor. Mol. Brain Res. 68, 181-185
25. Sliskovic, D.R. and White, A.D. (1991) Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents. Trends Pharmacol. Sci. 12, 194-199
26. Sparks, D.L. et al. (1994) Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126, 88-94
27. Schmechel, D. and Sullivan, P. (2002) High saturated fat diets are associated with a β deposition in primates. Neurobiol. Aging 23, 323
28. Refolo, L.M. et al. (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321-331
29. Shie, F.S. et al. (2002) Diet-induced hypercholesterolemia enhances brain Aβ accumulation in transgenic mice. Neuroreport 13, 455-459
30. Howland, D.S. et al. (1998) Modulation of secreted β-amyloid precursor protein and amyloid β-peptide in brain by cholesterol. J. Biol. Chem. 273, 16576-16582
31. Beffert, U. and Poirier, J. (1996) Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann. New York Acad. Sci. 777, 166-174
32. Beffert, U. et al. (1999) Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures. Mol. Brain Res. 68, 181-185
33. Holtzman, D.M. et al. (1999) Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103, R15-R21
34. Puglielli, L. et al. (2001) Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide. Nat. Cell Biol. 3, 905-912
35. Bodovitz, S. and Klein, W.L. (1996) Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440